Welcome to LookChem.com Sign In|Join Free

CAS

  • or
2-Carene, a bicyclic monoterpene, is widely found in the essential oils of plants such as cypress, cedar, and pine. Characterized by its sweet, earthy, and pine-like aroma, it is recognized for its potential anti-inflammatory and analgesic properties, which contribute to its value in traditional medicine. Moreover, 2-Carene has garnered interest as a potential renewable fuel source due to its high energy density. However, it is important to note that 2-Carene can act as a respiratory irritant, with high concentrations potentially causing respiratory irritation and inflammation.

554-61-0 Suppliers

Post Buying Request

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier
  • 554-61-0 Structure
  • Basic information

    1. Product Name: 2-CARENE
    2. Synonyms: (±)-car-2-ene;3,7,7-trimethylbicyclo[4.1.0]-2-heptene;4-delta-carene;bicyclo[4.1.0]hept-2-ene,3,7,7-trimethyl-;car-2-ene;delta-2-Carene;delta-4-carene;2-CARENE
    3. CAS NO:554-61-0
    4. Molecular Formula: C10H16
    5. Molecular Weight: 136.23
    6. EINECS: N/A
    7. Product Categories: N/A
    8. Mol File: 554-61-0.mol
  • Chemical Properties

    1. Melting Point: 25°C
    2. Boiling Point: 167.55°C
    3. Flash Point: 38.3°C
    4. Appearance: /
    5. Density: 0.8455 (estimate)
    6. Refractive Index: 1.4740
    7. Storage Temp.: N/A
    8. Solubility: N/A
    9. CAS DataBase Reference: 2-CARENE(CAS DataBase Reference)
    10. NIST Chemistry Reference: 2-CARENE(554-61-0)
    11. EPA Substance Registry System: 2-CARENE(554-61-0)
  • Safety Data

    1. Hazard Codes: N/A
    2. Statements: N/A
    3. Safety Statements: N/A
    4. RIDADR: 1993
    5. WGK Germany:
    6. RTECS:
    7. HazardClass: 3.2
    8. PackingGroup: III
    9. Hazardous Substances Data: 554-61-0(Hazardous Substances Data)

554-61-0 Usage

Uses

Used in Fragrance and Flavoring Industry:
2-Carene is used as a key ingredient in the production of fragrances and flavorings, leveraging its distinctive sweet, earthy, and pine-like scent to enhance the sensory experience of various products.
Used in Traditional Medicine:
In traditional medicine, 2-Carene is utilized for its potential anti-inflammatory and analgesic properties, making it a valuable component in treatments aimed at reducing inflammation and alleviating pain.
Used in Renewable Energy Industry:
2-Carene is considered for its potential use as a renewable fuel source, given its high energy density, which makes it a candidate for sustainable energy solutions.
It is important to manage exposure levels to 2-Carene in industrial applications to mitigate the risk of respiratory irritation and inflammation associated with high concentrations of this compound.

Check Digit Verification of cas no

The CAS Registry Mumber 554-61-0 includes 6 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 3 digits, 5,5 and 4 respectively; the second part has 2 digits, 6 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 554-61:
(5*5)+(4*5)+(3*4)+(2*6)+(1*1)=70
70 % 10 = 0
So 554-61-0 is a valid CAS Registry Number.
InChI:InChI=1/C10H16/c1-7-4-5-8-9(6-7)10(8,2)3/h6,8-9H,4-5H2,1-3H3

554-61-0SDS

SAFETY DATA SHEETS

According to Globally Harmonized System of Classification and Labelling of Chemicals (GHS) - Sixth revised edition

Version: 1.0

Creation Date: Aug 14, 2017

Revision Date: Aug 14, 2017

1.Identification

1.1 GHS Product identifier

Product name 2-Carene

1.2 Other means of identification

Product number -
Other names -

1.3 Recommended use of the chemical and restrictions on use

Identified uses For industry use only.
Uses advised against no data available

1.4 Supplier's details

1.5 Emergency phone number

Emergency phone number -
Service hours Monday to Friday, 9am-5pm (Standard time zone: UTC/GMT +8 hours).

More Details:554-61-0 SDS

554-61-0Synthetic route

3,7,7-trimethyl-cyclohepta-1,3,5-triene
3479-89-8

3,7,7-trimethyl-cyclohepta-1,3,5-triene

A

1,1,4-trimethylcycloheptane
2158-55-6

1,1,4-trimethylcycloheptane

B

2-carene
554-61-0

2-carene

C

1,5,5-trimethylcycloheptene
7348-54-1

1,5,5-trimethylcycloheptene

D

1,4,4-trimethylcycloheptene
4755-36-6

1,4,4-trimethylcycloheptene

E

carane
554-59-6

carane

F

3-carene
13466-78-9

3-carene

Conditions
ConditionsYield
With hydrogen; platinum In hexane at 20 - 22℃; Product distribution; various amounts of hydrogen;A 59%
B 0.7%
C 27.1%
D 9.4%
E 1.8%
F 1.4%
3,7-dimethylocta-1,6-dien-3-ol
78-70-6

3,7-dimethylocta-1,6-dien-3-ol

A

2-carene
554-61-0

2-carene

dl-camphene
565-00-4

dl-camphene

C

limonene.
138-86-3

limonene.

Conditions
ConditionsYield
In various solvent(s) at 90℃; for 1200h; Product distribution;A 19 % Chromat.
B 60 % Chromat.
C 21 % Chromat.
3-carene
13466-78-9

3-carene

A

1-methyl-4-isopropenylbenzene
1195-32-0

1-methyl-4-isopropenylbenzene

B

m-cymene
535-77-3

m-cymene

C

4-methylisopropylbenzene
99-87-6

4-methylisopropylbenzene

D

2-carene
554-61-0

2-carene

E

1,4,4-trimethylcycloheptene
4755-36-6

1,4,4-trimethylcycloheptene

F

1,4,5-trimethylcycloheptene

1,4,5-trimethylcycloheptene

Conditions
ConditionsYield
platinum on activated charcoal at 180 - 200℃; Product distribution; Mechanism; sealed tube, incomplete conversion;A 5 % Chromat.
B 15 % Chromat.
C 25 % Chromat.
D 5 % Chromat.
E 20 % Chromat.
F 20 % Chromat.
3-carene
13466-78-9

3-carene

B

3,7,7-trimethyl-cyclohepta-1,3,5-triene
3479-89-8

3,7,7-trimethyl-cyclohepta-1,3,5-triene

C

2-carene
554-61-0

2-carene

D

2,6,6-trimethyl-1,3-cycloheptadiene
32952-66-2

2,6,6-trimethyl-1,3-cycloheptadiene

E

1,5,5-trimethyl-1,3-cycloheptadiene
88070-29-5

1,5,5-trimethyl-1,3-cycloheptadiene

F

3,6,6-trimethylcycloheptene
88070-28-4

3,6,6-trimethylcycloheptene

Conditions
ConditionsYield
platinum on activated charcoal at 200℃; for 3h; Product distribution; sealed tube; other time; other temperature;A 0.5 % Chromat.
B 0.4 % Chromat.
C 4.0 % Chromat.
D 0.2 % Chromat.
E 0.6 % Chromat.
F 7.3 % Chromat.
3-carene
13466-78-9

3-carene

2-carene
554-61-0

2-carene

Conditions
ConditionsYield
With lithium 2-aminoethylamide
With ruthenium containing hydrotalcite at 210℃; for 2h; Inert atmosphere;
With 2-methylchlorobenzene; sodium In 5,5-dimethyl-1,3-cyclohexadiene for 24h; Solvent; Reflux;
3-carene
13466-78-9

3-carene

A

2-carene
554-61-0

2-carene

B

1,5,5-trimethylcycloheptene
7348-54-1

1,5,5-trimethylcycloheptene

C

1,4,4-trimethylcycloheptene
4755-36-6

1,4,4-trimethylcycloheptene

D

3,6,6-trimethylcycloheptene
88070-28-4

3,6,6-trimethylcycloheptene

Conditions
ConditionsYield
platinum on activated charcoal at 200℃; for 0.5h; sealed tube; Further byproducts given. Title compound not separated from byproducts;A 5.9 % Chromat.
B 9.1 % Chromat.
C 5.3 % Chromat.
D 4.9 % Chromat.
3,7,7-trimethyl-cyclohepta-1,3,5-triene
3479-89-8

3,7,7-trimethyl-cyclohepta-1,3,5-triene

A

1,1,4-trimethylcycloheptane
2158-55-6

1,1,4-trimethylcycloheptane

B

2-carene
554-61-0

2-carene

C

1,5,5-trimethylcycloheptene
7348-54-1

1,5,5-trimethylcycloheptene

D

1,4,4-trimethylcycloheptene
4755-36-6

1,4,4-trimethylcycloheptene

Conditions
ConditionsYield
With hydrogen; platinum In hexane at 20 - 22℃; Yield given. Further byproducts given. Title compound not separated from byproducts;
4-hydroxymethyl-2-carene
15103-32-9

4-hydroxymethyl-2-carene

A

2-carene
554-61-0

2-carene

B

3,4,7,7-tetramethyl-1,3,5-cycloheptatriene
100102-73-6

3,4,7,7-tetramethyl-1,3,5-cycloheptatriene

C

4-methyl-3(10),4-caradiene
103200-82-4, 106007-94-7

4-methyl-3(10),4-caradiene

D

3-carene
13466-78-9

3-carene

Conditions
ConditionsYield
With potassium hydroxide at 250℃; Product distribution;A 2.6 % Chromat.
B 28.6 % Chromat.
C 11.9 % Chromat.
D 3.5 % Chromat.
With potassium hydroxide at 250℃;A 2.6 % Chromat.
B 28.6 % Chromat.
C 11.9 % Chromat.
D 3.5 % Chromat.
(+)-Δ3-carene
498-15-7

(+)-Δ3-carene

γ aluminium oxide

γ aluminium oxide

2-carene
554-61-0

2-carene

Conditions
ConditionsYield
at 200 - 400℃;
(+)-Δ3-carene
498-15-7

(+)-Δ3-carene

sulfuric acid
7664-93-9

sulfuric acid

A

1-methyl-4-isopropyl-1,3-cyclohexadiene
99-86-5

1-methyl-4-isopropyl-1,3-cyclohexadiene

B

2-carene
554-61-0

2-carene

C

Δ1,3-m-Menthadien
145398-97-6

Δ1,3-m-Menthadien

(+)-Δ3-carene
498-15-7

(+)-Δ3-carene

titanic acid

titanic acid

A

1-methyl-4-isopropyl-1,3-cyclohexadiene
99-86-5

1-methyl-4-isopropyl-1,3-cyclohexadiene

B

2-carene
554-61-0

2-carene

C

Δ1,3-m-Menthadien
145398-97-6

Δ1,3-m-Menthadien

l-caryl-xanthogenic acid methyl ester

l-caryl-xanthogenic acid methyl ester

2-carene
554-61-0

2-carene

Conditions
ConditionsYield
bei der Destillation; l-Δ2-carene;
3-carene
13466-78-9

3-carene

A

m-cymene
535-77-3

m-cymene

B

4-methylisopropylbenzene
99-87-6

4-methylisopropylbenzene

C

2-carene
554-61-0

2-carene

Conditions
ConditionsYield
With 2-methylchlorobenzene; sodium In 5,5-dimethyl-1,3-cyclohexadiene for 48h; Solvent; Reflux;
2-carene
554-61-0

2-carene

C6H4N2O4S3
62925-73-9

C6H4N2O4S3

C16H20N2O4S3
131843-16-8

C16H20N2O4S3

Conditions
ConditionsYield
In diethyl ether for 2h; Ambient temperature;90%
3-methyl-2-thiophenecarboxaldehdye
5834-16-2

3-methyl-2-thiophenecarboxaldehdye

2-carene
554-61-0

2-carene

A

(1R,4R,5R)-2,2,6-trimethyl-4-(3-methylthiophen-2-yl)-3-oxabicyclo[3.3.1]non-6-ene

(1R,4R,5R)-2,2,6-trimethyl-4-(3-methylthiophen-2-yl)-3-oxabicyclo[3.3.1]non-6-ene

B

(1S,3aR,7aS)-3,3,6-trimethyl-1-(3-methylthiophen-2-yl)-1,3,3a,4,5,7a-hexahydroisobenzofuran

(1S,3aR,7aS)-3,3,6-trimethyl-1-(3-methylthiophen-2-yl)-1,3,3a,4,5,7a-hexahydroisobenzofuran

Conditions
ConditionsYield
With montmorillonite clay K10 In neat (no solvent) at 20℃; for 20h;A 2%
B 86%
2-carene
554-61-0

2-carene

A

7,7-Dimethyl-3-methylene-bicyclo[4.1.0]hept-2-yl-hydroperoxide

7,7-Dimethyl-3-methylene-bicyclo[4.1.0]hept-2-yl-hydroperoxide

B

3,7,7-Trimethyl-bicyclo[4.1.0]hept-3-en-2-yl-hydroperoxide

3,7,7-Trimethyl-bicyclo[4.1.0]hept-3-en-2-yl-hydroperoxide

Conditions
ConditionsYield
With oxygen In methanol at 16 - 20℃; Irradiation;A 22%
B 78%
2-carene
554-61-0

2-carene

1,1-dibromomethane
74-95-3

1,1-dibromomethane

3,3,7-trimethyltricyclo<5.1.0.02,4>octane
33046-07-0, 56614-85-8

3,3,7-trimethyltricyclo<5.1.0.02,4>octane

Conditions
ConditionsYield
With acetyl chloride; copper(l) chloride; zinc In diethyl ether Heating;76%
5-bromo-2-thiophencarboxaldehyde
4701-17-1

5-bromo-2-thiophencarboxaldehyde

2-carene
554-61-0

2-carene

A

(1S,3aR,7aS)-3,3,6-trimethyl-1-(5-bromothiophen-2-yl)-1,3,3a,4,5,7a-hexahydroisobenzofuran

(1S,3aR,7aS)-3,3,6-trimethyl-1-(5-bromothiophen-2-yl)-1,3,3a,4,5,7a-hexahydroisobenzofuran

B

(1R,4R,5R)-2,2,6-trimethyl-4-(5-bromothiophen-2-yl)-3-oxabicyclo[3.3.1]non-6-ene

(1R,4R,5R)-2,2,6-trimethyl-4-(5-bromothiophen-2-yl)-3-oxabicyclo[3.3.1]non-6-ene

Conditions
ConditionsYield
With montmorillonite clay K10 In neat (no solvent) at 20℃; for 20h;A 73%
B 15%
2-carene
554-61-0

2-carene

2,2-dimethyl cyclohepta-3,5-diene-1-one

2,2-dimethyl cyclohepta-3,5-diene-1-one

Conditions
ConditionsYield
With oxygen; 2-ethoxycarbonyl-1-cyclopentanone; cobalt(II) [bis(salicylidene-N-(methyl-3-hydroxypropionate))] In acetonitrile at 25℃;67%
2-carene
554-61-0

2-carene

palladium dichloride

palladium dichloride

Pd2Cl2(C10H15)2
89606-45-1

Pd2Cl2(C10H15)2

Conditions
ConditionsYield
With potassium acetate In acetic acid equimolar amts., 55-60°C, 4 h; elem. anal.;65%
2-carene
554-61-0

2-carene

trimethyltin(IV)chloride
1066-45-1

trimethyltin(IV)chloride

10-(trimethylstannyl)-2-carene
100692-36-2

10-(trimethylstannyl)-2-carene

Conditions
ConditionsYield
With BuLi-TMEDA In not given car-2-ene was metallated with BuLi-TMEDA, then trapped with Me3SnCl; GC, IR, NMR, mass spectra;47%
2-carene
554-61-0

2-carene

A

1-methyl-4-isopropyl-1,3-cyclohexadiene
99-86-5

1-methyl-4-isopropyl-1,3-cyclohexadiene

B

4-methylisopropylbenzene
99-87-6

4-methylisopropylbenzene

C

isoterpinolene
586-63-0

isoterpinolene

D

3-carene
13466-78-9

3-carene

Conditions
ConditionsYield
thionin-supported zeolite Na-Y In hexane at 20℃; for 0.5h; Product distribution;A 25%
B 18%
C 40%
D 10%
2-carene
554-61-0

2-carene

paraformaldehyde

paraformaldehyde

trans-2-hydroxymethyl-3-carene
70424-76-9, 123476-20-0

trans-2-hydroxymethyl-3-carene

Conditions
ConditionsYield
at 180℃; for 6h;38%
2-carene
554-61-0

2-carene

A

2,2-dimethyl-6-methylene-3-oxa-bicyclo[3.3.1]nonane
30558-01-1, 35117-72-7

2,2-dimethyl-6-methylene-3-oxa-bicyclo[3.3.1]nonane

B

3,7,7-trimethyl-8,10-dioxatricyclo<5.4.0.02,4>undecane
123476-22-2

3,7,7-trimethyl-8,10-dioxatricyclo<5.4.0.02,4>undecane

trans-2-hydroxymethyl-3-carene
70424-76-9, 123476-20-0

trans-2-hydroxymethyl-3-carene

D

3,3-dimethyl-10-methylene-8-oxatricyclo<4.3.1.02,4>decane
76690-03-4

3,3-dimethyl-10-methylene-8-oxatricyclo<4.3.1.02,4>decane

trans-2-acetoxymethyl-3-carene
84864-55-1, 123476-21-1

trans-2-acetoxymethyl-3-carene

Conditions
ConditionsYield
With formaldehyd In acetic acid at 120℃; for 48h; Mechanism;A 3%
B 2%
C 7%
D 5%
E 28%
2-carene
554-61-0

2-carene

paraformaldehyde

paraformaldehyde

A

2,2-dimethyl-6-methylene-3-oxa-bicyclo[3.3.1]nonane
30558-01-1, 35117-72-7

2,2-dimethyl-6-methylene-3-oxa-bicyclo[3.3.1]nonane

trans-2-hydroxymethyl-3-carene
70424-76-9, 123476-20-0

trans-2-hydroxymethyl-3-carene

C

3,3-dimethyl-10-methylene-8-oxatricyclo<4.3.1.02,4>decane
76690-03-4

3,3-dimethyl-10-methylene-8-oxatricyclo<4.3.1.02,4>decane

trans-2-acetoxymethyl-3-carene
84864-55-1, 123476-21-1

trans-2-acetoxymethyl-3-carene

Conditions
ConditionsYield
at 120℃; for 48h; Further byproducts given;A 3%
B 7%
C 5%
D 28%
2-carene
554-61-0

2-carene

paraformaldehyde

paraformaldehyde

A

3,7,7-trimethyl-8,10-dioxatricyclo<5.4.0.02,4>undecane
123476-22-2

3,7,7-trimethyl-8,10-dioxatricyclo<5.4.0.02,4>undecane

trans-2-hydroxymethyl-3-carene
70424-76-9, 123476-20-0

trans-2-hydroxymethyl-3-carene

C

3,3-dimethyl-10-methylene-8-oxatricyclo<4.3.1.02,4>decane
76690-03-4

3,3-dimethyl-10-methylene-8-oxatricyclo<4.3.1.02,4>decane

trans-2-acetoxymethyl-3-carene
84864-55-1, 123476-21-1

trans-2-acetoxymethyl-3-carene

Conditions
ConditionsYield
at 120℃; for 48h; Further byproducts given;A 2%
B 7%
C 5%
D 28%
4-Bromothiophen-2-aldehyde
18791-75-8

4-Bromothiophen-2-aldehyde

2-carene
554-61-0

2-carene

(1R,4R,5R)-2,2,6-trimethyl-4-(4-bromothiophen-2-yl)-3-oxabicyclo[3.3.1]non-6-ene

(1R,4R,5R)-2,2,6-trimethyl-4-(4-bromothiophen-2-yl)-3-oxabicyclo[3.3.1]non-6-ene

Conditions
ConditionsYield
With montmorillonite clay K10 In neat (no solvent) at 20℃; for 20h;20%
5-nitrofurane-2-carboxaldehyde
698-63-5

5-nitrofurane-2-carboxaldehyde

2-carene
554-61-0

2-carene

(1R,4R,5R)-2,2,6-trimethyl-4-(5-nitrofuran-2-yl)-3-oxabicyclo[3.3.1]non-6-ene

(1R,4R,5R)-2,2,6-trimethyl-4-(5-nitrofuran-2-yl)-3-oxabicyclo[3.3.1]non-6-ene

Conditions
ConditionsYield
With montmorillonite clay K10 In neat (no solvent) at 20℃; for 20h;18%
2-carene
554-61-0

2-carene

acetic acid
64-19-7

acetic acid

1-methyl-4-isopropyl-1,3-cyclohexadiene
99-86-5

1-methyl-4-isopropyl-1,3-cyclohexadiene

Conditions
ConditionsYield
d-Δ4-carene;
2-carene
554-61-0

2-carene

thallium(III) triacetate
2570-63-0

thallium(III) triacetate

A

p-cymene-8-ol
1197-01-9

p-cymene-8-ol

B

(+)-cis/trans-p-mentha-2,8-dien-1-ol
491-05-4

(+)-cis/trans-p-mentha-2,8-dien-1-ol

Acetic acid (1R,6S)-6-hydroxy-5-isopropenyl-2-methyl-cyclohex-2-enyl ester

Acetic acid (1R,6S)-6-hydroxy-5-isopropenyl-2-methyl-cyclohex-2-enyl ester

Acetic acid (1S,4R,5R,6R)-5-hydroxy-1,3,3-trimethyl-2-oxa-bicyclo[2.2.2]oct-6-yl ester

Acetic acid (1S,4R,5R,6R)-5-hydroxy-1,3,3-trimethyl-2-oxa-bicyclo[2.2.2]oct-6-yl ester

Conditions
ConditionsYield
In acetic acid at 20℃; Further byproducts given;A 0.4 g
B 0.5 g
C n/a
D n/a
2-carene
554-61-0

2-carene

A

p-cymene-8-ol
1197-01-9

p-cymene-8-ol

B

(+)-cis/trans-p-mentha-2,8-dien-1-ol
491-05-4

(+)-cis/trans-p-mentha-2,8-dien-1-ol

C

6-(1-hydroxy-1-methylethyl)-3-methyl-2-cyclohexen-1-one
87791-00-2

6-(1-hydroxy-1-methylethyl)-3-methyl-2-cyclohexen-1-one

p-menth-1-en-3β,8-diol

p-menth-1-en-3β,8-diol

Conditions
ConditionsYield
With sodium hydroxide; thallium(III) acetate 1) glacial acetic acid, 20 deg C, 3 d; 2) EtOH, 80 deg C, 6 h; Yield given. Multistep reaction. Further byproducts given. Yields of byproduct given;
2-carene
554-61-0

2-carene

A

p-cymene-8-ol
1197-01-9

p-cymene-8-ol

B

(+)-cis/trans-p-mentha-2,8-dien-1-ol
491-05-4

(+)-cis/trans-p-mentha-2,8-dien-1-ol

p-menth-1-en-3α,8-diol

p-menth-1-en-3α,8-diol

p-menth-1-en-3β,8-diol

p-menth-1-en-3β,8-diol

Conditions
ConditionsYield
With sodium hydroxide; thallium(III) acetate 1) glacial acetic acid, 20 deg C, 3 d; 2) EtOH, 80 deg C, 6 h; Yield given. Multistep reaction. Further byproducts given. Yields of byproduct given;
2-carene
554-61-0

2-carene

A

8-hydroxy-m-cymene
5208-37-7

8-hydroxy-m-cymene

B

β-phellandrene-8-ol
65293-09-6

β-phellandrene-8-ol

C

p-menth-2-ene-1α,7-diol
57030-53-2

p-menth-2-ene-1α,7-diol

D

6-(1-hydroxy-1-methylethyl)-3-methyl-2-cyclohexen-1-ol
6252-34-2

6-(1-hydroxy-1-methylethyl)-3-methyl-2-cyclohexen-1-ol

Conditions
ConditionsYield
With lead(IV) acetate; sodium hydroxide; acetic anhydride 1.) glacial acetic acid, 20 deg C, 5 h, 2.) H2O, EtOH, 80 deg C, 5 h; Yield given. Multistep reaction. Further byproducts given. Yields of byproduct given;
2-carene
554-61-0

2-carene

A

β-phellandrene-8-ol
65293-09-6

β-phellandrene-8-ol

B

p-menth-2-ene-1α,7-diol
57030-53-2

p-menth-2-ene-1α,7-diol

C

6-(1-hydroxy-1-methylethyl)-3-methyl-2-cyclohexen-1-ol
6252-34-2

6-(1-hydroxy-1-methylethyl)-3-methyl-2-cyclohexen-1-ol

D

2-acetyl-6,6-dimethylbicyclo<3.1.0>hexane
57906-15-7, 57906-16-8, 80780-01-4, 80780-02-5, 94480-67-8

2-acetyl-6,6-dimethylbicyclo<3.1.0>hexane

Conditions
ConditionsYield
With lead(IV) acetate; sodium hydroxide; acetic anhydride 1.) glacial acetic acid, 20 deg C, 5 h, 2.) H2O, EtOH, 80 deg C, 5 h; Yield given. Multistep reaction. Further byproducts given. Yields of byproduct given;
2-carene
554-61-0

2-carene

(1R,3S)-methyl 2,2-dimethyl-3-(3-oxobutyl)cyclopropanecarboxylate
73175-23-2

(1R,3S)-methyl 2,2-dimethyl-3-(3-oxobutyl)cyclopropanecarboxylate

Conditions
ConditionsYield
With ozone

554-61-0Relevant articles and documents

AN INVESTIGATION OF TERPENE HYDROCARBONS OF THE CARANE SERIES BY PHOTOELECTRON SPECTROSCOPY

Chuiko, V. A.,Manukov, E. N.,Chukhov, Yu. V.,Timoshenko, M. M.

, p. 600 - 605 (1985)

2- and 3-Carenes and carane have been studied by PE spectroscopy.On the basis of an analysis of orbital interactions and information obtained from the PE spectra of model compounds an assignment has been made of the bands corresponding to ionization from the molecular orbitals of the double bond and of the cyclopropane ring.

Solvent-free isomerization of 3-carene to 2-carene using Na/o-chlorotoluene catalyst in trans-isolimonene production

Julianto, Tatang Shabur,Jumina,Jojo, Hardjono Sastrohamid,Mustofa

, p. 3107 - 3111 (2018/01/17)

Trans-isolimonene is one of the important compound in drugs development. This compound can be made by isomerization of inexpensive 3-carene via 2-carene using Na/o-chlorotoluene catalyst in xylene. The existence of xylene as a solvent requires a further separation process that can reduce the efficiency when applied in the bulk industry. The isomerization of 3-carene to 2-carene has been studied in solvent free reaction compared by isomerization without xylene solvent. The result showed that the isomerization can also occur in solvent-free condition. Solventfree isomerization gave 27.72% of conversion and 83.27% of selectivity while isomerization with solvent gave 23.59% of conversion and 86.87% of selectivity.

Ruthenium containing hydrotalcite as a solid base catalyst for >C{double bond, long}C< double bond isomerization in perfumery chemicals

Sharma, Sumeet K.,Parikh, Parimal A.,Jasra, Raksh V.

experimental part, p. 27 - 33 (2010/04/28)

Ruthenium containing hydrotalcite (Ru-Mg-Al) is used as a solid base catalyst for >C{double bond, long}C2 and Ru-alumina for isomerization of methyl chavicol to trans-anethole. Ru-Mg-Al catalyst was reused four times without loss in its activity, however, significant loss in the conversion of methyl chavicol and selectivity of trans-anethole was observed on reusability of other ruthenium impregnated catalysts. The conversion of methyl chavicol and selectivity of trans-anethole was found to increase on increasing the reaction temperature as well as amount of catalyst. At 0.005 g catalyst amount, 55% conversion of methyl chavicol with 68% selectivity of trans-anethole was observed that increased to 93% with 82% selectivity of trans-anethole at 0.05 g catalyst amount. On further increase in the amount of catalyst to 1 g, conversion increased to 98% with 88% selectivity of trans-anethole.

Platinum- and gold-catalyzed rearrangement reactions of propargyl acetates: Total syntheses of (-)-α-cubebene, (-)-cubebol, sesquicarene and related terpenes

Fuerstner, Alois,Hannen, Peter

, p. 3006 - 3019 (2008/02/04)

Propargyl acetates, in the presence of catalytic amounts of late transition-metal salts such as PtCl2 or AuCl3, represent synthetic equivalents of α-diazoketones. This notion is corroborated by a concise approach to various sesquiterpene natural products starting from readily available substrates. Specifically, (+)-carvomenthone (17) is converted into propargyl acetate (S)-26 by a sequence involving Stille cross-coupling of its kinetic enol triflate 18, regioselective hydroboration/oxidation of the resulting 1,3-diene 19, and addition of an alkynyl cerium reagent to aldehyde 21 thus obtained. Since the latter step was found to be unselective, the configuration of the reacting propargyl acetate was unambiguously set by oxidation followed by diastereoselective transfer hydrogenation by using Noyori's catalyst 25. Compound (5)-26, on treatment with PtCl2 in toluene, converted exclusively to the tricyclic enol acetate 27, which was sap onified to give norcubebone 11 in excellent overall yield. The conversion of this compound into the sesquiterpene alcohol (-)-cubebol (6) was best achieved with MeCeCl2 as the nucleophile, whereas the formation-of the parent hydrocarbon (-)-α-cubebene (4) was effected in excellent yield by recourse to iron-catalyzed cross coupling methodology developed in this laboratory. Since norketone 11 has previously been transformed into (-)-β-cubebene (5) as well as (-)-4-epicubebol 8, our approach constitutes formal total syntheses of these additional natural products as well. Along similar lines, the readily available propargyl acetates 1, 33 and 47 were shown to give access to 2-carene 44, sesquicarene 39, and episesquicarene 51 in excellent overall yields. In this series, however, the cy cloisomerization reaction was best achieved with catalytic amounts of AuCl3 in 1,2-dichloroethane as the solvent. In addition to these preparative results, our data provide some insight into the mechanism of these remarkable skeletal rearrangement reactions. Transformations of this type are likely triggered by initial coordination of the alkyne unit of the substrate to the carbophilic transition-metal cation. Formal attack of the alkene moiety onto the resulting π-complex engenders the formation of an electrophilic cyclopropyl carbene species which subsequently reacts with the adjacent acetate unit to give the final product. The alternative phasing of events, implying initial attack of the acetate (rather than the alkene moiety) onto the metal-alkyne complex, is inconsistent with the stereochemioal data obtained during this total synthesis campaign.

Intramolecular cyclopropanation reactions of organozinc carbenoids derived from terpenoid enals

Motherwell, William B.,Roberts

, p. 1121 - 1124 (2007/10/02)

Treatment of a series of unsaturated terpenoid enals with 1,2 bis (chlorodimethylsilyl) ethane and zinc provides a simple and efficient method for intramolecular cyclopropanation.

TRANSFORMATIONS OF 4-HYDROXYMETHYL-2-CARENE OVER POTASSIUM HYDROXIDE

Manukov, E. N.,Vyglazov, O. G.,Chuiko, V. A.,Shingel', I. A.

, p. 1912 - 1914 (2007/10/02)

The dehydration of 4-hydroxymethyl-2-carene over potassium hydroxide at 250 deg C, which leads to the formation of 4-methyl-3(10),4-caradiene and 3,4,7,7-tetramethyl-1,3,5-cycloheptatriene, was investigated.The dehydration is accompanied by a small degree

DISPROPORTIONATION OF HYDROGEN IN 3-CARENE

Manukov, E. N.,Chuiko, V. A.,Vyglazov, O. G.

, p. 257 - 262 (2007/10/02)

The disproportionation of hydrogen in 3-carene takes place with the formation of compounds of the 1,1,4-trimethylcycloheptane series.The proposed reaction mechanism involves dehydration of the 2-carene to 2,4-caradiene, which exists in a rapid tautomeric equilibrium with 3,7,7-trimethyl-1,3,5-cycloheptatriene.This gives rise to the appearance of compounds with a seven-membered ring in the reaction product.

Liquid Crystalline Catalysis, 3, Monomolecular Rearrangements of Terpene Derivatives in Liquid Crystalline Solvents

Melone, S.,Mosini, V.,Nicoletti, R.,Samori, B.,Torquati, G.

, p. 399 - 410 (2007/10/02)

The ability of limonene and linalool to rearrange in mesomorphic media is apparently determined by the constraints exerted by the solvent structure on the translational diffusions of the reactant solute molecules.Selective conversions seem to be promoted by the different media.Alkylcyclohexyl- and alkylbicyclohexyl-carboxylic acids and their mixtures with toluic acid have been used as solvents.The B structure of their smectic phases has been demonstrated by X-ray diffraction studies.

HETEROGENEOUS HYDROGENATION OF 3,7,7-TRIMETHYLCYCLOHEPTA-1,3,5-TRIENE

Manukov, E. N.,Chuiko, V. A.

, p. 422 - 425 (2007/10/02)

It has been shown that the intermediate products of the hydrogenation of 3,7,7-trimethylcyclohepta-1,3,5-triene on platinum black are 2- and 3-carenes, in addition to olefins and dienes of the 1,1,4-trimethylcycloheptane series.The final hydrogenation products contains 96percent of 1,1,4-trimethylcycloheptane and 4percent of carenes.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 554-61-0